CNC · Centene Corporation
$35.102026-05-17Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Managed Health Care
Intrinsic Value Range Comparison · Mulya.ai
Bull
$213
+505.7% vs market
Base · active
$54
+55.1% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($54 · $213) Analysts Range ($38 · $59) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $126.0B | — | 1.4% | 26.3% | $1.3B | $1.5B | $2.8B | 4.3% | — | 4.2% | $31.2B | $2.74 | — |
| 2022.Q4 | $144.5B | 14.7% | 0.9% | 38.7% | $807MM | $3.8B | $4.6B | 5.9% | — | 2.7% | $27.9B | $2.45 | — |
| 2023.Q4 | $154.0B | 6.5% | 1.9% | 25.0% | $2.2B | $4.5B | $6.7B | 5.8% | — | 8.4% | $24.2B | $5.50 | — |
| 2024.Q4 | $163.1B | 5.9% | 1.9% | 22.6% | $2.5B | −$2.9B | −$471MM | 6.5% | — | 9.3% | $28.4B | $6.73 | — |
| 2025.Q4 | $194.8B | 19.4% | -3.9% | 0.8% | −$7.6B | $883MM | −$6.7B | 6.4% | — | -31.1% | $20.2B | $-13.59 | — |
| italics below = DCF projection · 10yr Rev CAGR: 2.6% |
| 2026.Q4 | $189.8B | +-2.6% | 1.3% | 2.7% | $2.3B | $0MM | $2.3B | 10.7% | $2.1B | 11.6% | $20.2B | $4.77 | 7.4 |
| 2027.Q4 | $190.0B | +0.1% | 1.6% | 4.6% | $3.0B | −$1MM | $3.0B | 10.4% | $2.4B | 14.7% | $20.2B | $6.06 | 5.8 |
| 2028.Q4 | $195.8B | +3.1% | 2.2% | 6.5% | $4.0B | −$51MM | $4.0B | 10.2% | $2.9B | 19.8% | $20.3B | $8.17 | 4.3 |
| 2029.Q4 | $202.0B | +3.2% | 3.2% | 8.4% | $5.9B | $0MM | $5.9B | 10.0% | $4.0B | 29.0% | $20.3B | $11.99 | 2.9 |
| 2030.Q4 | $208.8B | +3.4% | 3.2% | 10.4% | $6.0B | $0MM | $6.0B | 9.8% | $3.7B | 29.4% | $20.3B | $12.13 | 2.9 |
|
| Term. Yr+ | $262.0B | 4.1% | 2.4% | 20.0% | $5.1B | −$2.4B | $2.7B | 8.6% | $23.8B | 8.7% | — | — | — |
Active scenario IV: $54 (+55.1% vs market)